US 11191837
Recombinant VWF formulations
granted A61KA61K38/1709A61K38/36
Quick answer
US patent 11191837 (Recombinant VWF formulations) held by Takeda Pharmaceutical Company Limited expires Mon Dec 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Dec 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K38/1709, A61K38/36, A61K38/37, A61K47/02